Skin Barrier Assessment in Pregnancy and at Birth

Status unconfirmed

Conditions studied: Pregnancy Related, Allergy, Atopic Dermatitis Eczema, Asthma in Children, Food Allergy

In brief

This is a prospective birth cohort study assessing the role of maternal and environmental factors on the development of allergic diseases in children. Pregnant mothers will be enrolled and we will examine her skin barrier with skin tape strips (STS) and transepidermal water loss (TEWL), along with blood work. We will then follow her offspring and perform similar testing, along with detailed questionnaires inquiring about exposures such as use of detergents and soaps, sunlight exposure, and pollution exposure. When the infant is around 12 months old, we will contact the family via telephone to see if the child developed any allergic conditions within their first year of life, such as eczema, food allergy, or wheezing. A final questionnaire will be performed.

Key facts

Study ID

NCT04445298

Run by

National Jewish Health

People needed

160

Starts

2020-08-03

Expected to finish

2022-07-01

Last updated by the study team

2020-09-10

Who can join

Age: any, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Inclusion criteria of the pregnant women:
• Pregnant women at any stage of a singleton pregnancy.
• Inclusion criteria of the infant:
• Infant is the offspring of a woman enrolled in the study.

You may not qualify if…

• Exclusion criteria of all subjects:
• Use of systemic immunosuppressive drugs including oral steroids within 30 days of skin barrier assessment
• Has received total body phototherapy (e.g., ultraviolet light B [UVB], psoralen plus ultraviolet light A [PUVA], tanning beds [>1 visit per week]) within 30 days of skin barrier assessment
• Use of topical corticosteroids, topical immunomodulatory agents, or topical antibiotics on the extremity being evaluated within 7 days of skin barrier assessment
• Use of systemic antibiotics, antiparasitics, antivirals, or antifungals within 7 days, or antihistamines within 5 days of skin barrier assessment
• Has taken a bleach bath within 7 days of skin barrier assessment
• Use of emollients on the extremity being evaluated within 24 hours of skin barrier assessment
• Has taken a bath or shower on the day of the skin barrier assessment
• Exclusion criteria of the pregnant women:
• Pregnant women with high risk pregnancies.
• Pregnancy is from an egg donation.
• Pregnant women pregnant with more than one fetus.
• Pregnant women with psychiatric and developmental co-morbidities that would render them unable to provide informed consent or perform study-related procedures.
• AIDS and HIV infection.
• A fetus with chromosomal or congenital abnormalities, a heritable hematological disorder like thalassemia or sickle cell disease in the mother.
• Exclusion criteria of the infant:
• Infant is delivered earlier than 34 weeks gestation.
• Infant is born with a significant birth defect or medical condition where enrollment in this study is not in the infant's best interest.

Where it is running

• National Jewish Health — Denver, Colorado, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.